Navigation Links
Sheba Medical Center's Dr. Talia Golan Helps Discover a Potential New Treatment for Metastatic Pancreatic Cancer
Date:6/3/2019

Dr. Talia Golan, the head of Sheba Medical Center's Pancreatic Cancer Center, who has been conducting on-going research and clinical trials with Astrazeneca and MSD (Merck), two of the world's largest biopharmaceutical companies, to evaluate the safety and test the efficacy of a new drug treatment regimen known as POLO in order to treat a specific type of metastatic pancreatic cancer ( in carriers of the BRCA 1 & 2 mutation) within patients around the globe, has reported very promising results in the prestigious New England Journal of Medicine.

"The POLO trial using the medicine Lynparza offers potential hope for those who suffer from metastatic pancreatic cancer and have a BRCA mutation," Dr. Golan revealed. “This treatment also exemplifies the advent of 'precision medicine' based on a specific genetic biomarker, BRCA 1 & 2."

Pancreatic cancer is the 12th most common cancer worldwide, with 458,918 new cases in 2018 alone. It is the 4th leading cause of cancer death, and less than 3% of patients with metastatic disease survive more than five years after diagnosis. Early diagnosis of pancreatic cancer is difficult, as often there are no symptoms until it is too late. Around 80% of patients are diagnosed at the metastatic stage.

What are BRCA Mutations?...
BRCA1 and BRCA2 are human genes that produce proteins responsible for repairing damaged DNA and play an important role in maintaining the genetic stability of cells. When either of these genes is mutated, or altered, such that its protein product either is not made or does not function correctly, DNA damage may not be repaired properly, and cells become unstable. As a result, cells are more likely to develop additional genetic alterations that can lead to cancer. A significant number of Ashkenazi Jews (European origin) around the world are carriers of the BRCA 1 & 2 genes.

About Dr. Talia Golan
Dr. Golan is a medical oncologist, specializing in gastrointestinal malignancies, and is recognized as a world-renowned specialist and researcher in the field of pancreatic cancer. Dr. Golan is also the director of Phase I clinical trials unit at Sheba's Pancreatic Cancer Center.

About Sheba Medical Center, Tel HaShomer
Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East. Sheba is the only medical center in Israel that combines an acute care hospital and a rehabilitation hospital on one campus, and it is at the forefront of medical treatments, patient care, research and education. In 2019, Newsweek magazine named Sheba one of the "Top 10 Hospitals in the World". To learn more, visit: eng.sheba.co.il.

About the POLO trial and Lynparza
POLO is a Phase III randomized, double-blinded, placebo-controlled, multi-center study of Lynparza tablets (300mg twice daily) as maintenance monotherapy vs. placebo. The trial randomized 154 patients with gBRCAm metastatic pancreatic cancer whose disease has not progressed on 1st-line platinum-based chemotherapy.

Lynparza (olaparib) is a first-in-class PARP inhibitor and the first targeted treatment to block DNA damage response (DDR) in cells/tumours harbouring a deficiency in homologous recombination repair (HRR), such as mutations in BRCA1 and/or BRCA2.

Read the full story at https://www.prweb.com/releases/sheba_medical_center_s_dr_talia_golan_helps_discover_a_potential_new_treatment_for_metastatic_pancreatic_cancer/prweb16352728.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Sunday, Oct. 14: Friends of Sheba Medical Center Hosts Anniversary Gala in Los Angeles
2. Israel’s Sheba Medical Center and Florida Atlantic University Team Up to Better Prepare South Florida for Large Scale, Mass Casualty Emergencies
3. Friends of Sheba Medical Center, Tel HaShomer Hosts Celebration of Partnership with MD Anderson in Houston
4. NBA Hall of Famer Dikembe Mutombo Plans Historic Visit to Israel’s Sheba Medical Center
5. Canadian Friends of Sheba Medical Center Holds VIP Reception with Sheba Director General in Toronto
6. Canadian Friends of Sheba Medical Center Holds VIP Reception with Sheba Director General in Toronto
7. Williams Island Welcomes Prof. Yitshak Kreiss – the Director General of the Largest Hospital In Israel, Sheba Medical Center, Tel HaShomer
8. Sheba Medical Center Doctors Dominate Forbes Israel’s Annual “Best Doctors in Israel” Edition
9. Vasomedical Announces Financial Results for the First Quarter of 2013
10. CCS Medical Moves Forward as Medicare Winner
11. PENTAX Medical Launches Industrys Highest* Resolution HD+ Imaging Technology For Flexible Endoscopy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... ... June 19, 2019 , ... ... Practices for Regulatory, Compliance and Quality Professionals, **An FDAnews Webinar**, Monday, June ... the cleanrooms? What are the latest cleaning regulations? Is one using the ...
(Date:6/19/2019)... LUIS OBISPO, Calif. (PRWEB) , ... June 19, 2019 , ... “We sometimes take out ... brushing and flossing, and regular checkups we seldom think about our teeth unless it’s baby’s ... Our teeth help us chew, speak, smile and have a very important role in our ...
(Date:6/19/2019)... ... ... A new survey by The Senior Citizens League (TSCL) indicates ... If that doesn’t sound like enough of a challenge, at a time when ... spending $1,000 per month or more. The same survey also found that, of ...
Breaking Medicine Technology:
(Date:6/16/2019)... , ... June 15, 2019 , ... All families go ... poverty, untreated mental health needs and lack of a support network, they may be ... to remove the children from the home and place them with a relative, familiar ...
(Date:6/14/2019)... ... June 14, 2019 , ... United Breast Cancer Foundation ... for Saturday, July 13th. UBCF is thrilled to return to the “City of ... cancer. This second event was added after an overwhelming response to the Tempur-Pedic® ...
(Date:6/13/2019)... ... June 13, 2019 , ... Endometriosis is a painful, inflammatory disease that occurs when ... , Painful periods , Heavy bleeding , Irregular menstruation , ... , Women’s Excellence uses the latest and newest treatment protocols in dealing with the ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... 30 Second Test (BL30SEC) has been accepted by the 2019 National Conference of ... Appendix N requirements. , The Charm BL30SEC test was validated by third ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... Hard money ... just 24 hours and the funds can also be provided quickly. If the documentation ... , Private lenders are able to avoid the federal oversight involved with a traditional ...
Breaking Medicine News(10 mins):